Effect of Omacor on Triglycerides in HIV Infected Subjects

Status:
Terminated

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

Omacor is likely to decrease lipid parameters in HIV infected subjects. In these subjects the lipid are decrease due to HAART treatment

Phase 4

Solvay Pharmaceuticals